MedPath

Comparison of Surgical Outcomes Between MPCNL and RIRS

Not Applicable
Completed
Conditions
Renal Stone
Interventions
Device: RIRS
Device: MPCNL
Registration Number
NCT02067221
Lead Sponsor
Seoul National University Hospital
Brief Summary

The objective of this research is to investigate the surgical outcomes of minimally invasive percutaneous nephrolithotomy(MPCNL) and retrograde intrarenal surgery (RIRS)for patients with renal stone larger than 1cm.

Detailed Description

It is pointed out that there is the disadvantage of conventional PCNL technique which showed dramatic decrease in Hb and renal damage even though it has some advantages of a short operation time and a high stone-free rate. MPCNL and RIRS has recently been considered as very efficacious methods.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • The person who has been diagnosed with renal stone larger than 1cm renal and who has been supposed to undergo MPCNL or RIRS.
  • The person who signed up for participation and agree with intention of clinical test.
Read More
Exclusion Criteria
  • The patient whose medical record has been omitted from database.
  • The patient who has an anatomical abnormality of urinary tract and/or metabolic illness
  • The patient who do not agree with the intention of the clinical study.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RIRS (retrograde intrarenal surgery)RIRSUse of flexible ureteroscopy to access and remove renal stones without percutaneous nephrostomy tract
MPCNL (mini-perc)MPCNLA new technique that reduced the size of percutaneous tract to make renal stone into small pieces. Patients will be randomized and assigned to each group at the ratio 1:1
Primary Outcome Measures
NameTimeMethod
stone-free ratepostoperative 1 month

We will check the non-contrast CT scan at postoperative 1month when the patient visit the outpatient department. If the patient does not have any residual stone fragment, it will be reported to 'success.' Otherwise, we will measure the size of each stone of residual fragments.

Secondary Outcome Measures
NameTimeMethod
painpostoperative 1 day

Visual analogue scale will be measured: 0 (no pain) -\> 10 (the most worst pain ever experienced)

hemoglobin droppostoperative 1 day

preoperative Hb level - Hb level of immediate postoperative 1 day

occurrence of complicationspostoperative 1 day, and the postop 1month at OPD

occurrence of stricture in non-contrast CT scan history taking of hematuria or fever

hospital staypostoperative 1 month

calculation of days of hospital stay

Trial Locations

Locations (1)

SMG-SNU Boramae Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath